For instance, upregulation of PYGB was reported in several cancers, such as colorectal cancer (Tashima et al., 2000), prostate cancer (Wang et al., 2018) NSCLC (Lee et al., 2006) and ovarian cancer (Zhou et al., 2019). Here, PYGB is linked to prostate carcinoma.